ProfileGDS5822 / ILMN_2701398
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 11% 14% 14% 10% 41% 16% 15% 58% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 110.411
GSM1276600PDAC Late Ablation Control 213.114
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 19.914
GSM1276603PDAC Late Ablation 28.710
GSM1276604PDAC Late Ablation 319.641
GSM1303940PDAC Late Ablation_anti-CTLA4 111.416
GSM1303941PDAC Late Ablation_anti-CTLA4 28.915
GSM1303942PDAC Late Ablation_anti-CTLA4 334.158